Literature DB >> 31276633

Non-coding RNAs in regulating gastric cancer metastasis.

Wei Feng1, Ye Ding1, Wei Zong1, Shaoqing Ju2.   

Abstract

Gastric cancer is one of the leading causes of cancer-related deaths worldwide, and mortality remains high, especially in East Asia. At present, the main method to diagnose gastric cancer is pathological biopsy. At the time of diagnosis, most patients have been diagnosed with advanced cancer and metastasis. The treatment of gastric cancer patients is mainly radical surgical resection and chemoradiotherapy, while patients with metastatic tumor have great challenges to radical surgery and are prone to drug resistance. Metastasis is an important factor affecting tumor development. In addition, evidence accumulated in the literature indicates that non-coding RNA plays a key role in tumor metastasis. This article reviews the role of ncRNAs in gastric cancer metastasis and discusses the regulatory mechanism in the development and treatment of gastric cancer.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug resistance; Epithelial-mesenchymal transition; Gastric cancer; Metastasis; Noncoding RNAs; Therapy

Year:  2019        PMID: 31276633     DOI: 10.1016/j.cca.2019.07.003

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  11 in total

1.  Studies of anticancer activity in vivo and in vitro behaviors of liposomes encapsulated iridium(III) complex.

Authors:  Yiying Gu; Haoyu Wen; Yuanyuan Zhang; Lan Bai; Yi Zhou; Huiwen Zhang; Li Tian; Jing Hao; Yunjun Liu
Journal:  J Biol Inorg Chem       Date:  2021-01-21       Impact factor: 3.358

2.  CircAKT3 promotes cell proliferation, survival and glutamine metabolism of gastric cancer by activating SLC1A5 expression via targeting miR-515-5p.

Authors:  Fei Li; Lixiao Zhang; Qi Sun
Journal:  Histol Histopathol       Date:  2021-12-01       Impact factor: 2.303

3.  Hsa_circ_0000437 promotes pathogenesis of gastric cancer and lymph node metastasis.

Authors:  Xianjuan Shen; Shan Kong; Shuo Ma; Lei Shen; Ming Zheng; Shiyi Qin; Jing Qi; Qiuhong Wang; Xiaopeng Cui; Shaoqing Ju
Journal:  Oncogene       Date:  2022-09-15       Impact factor: 8.756

4.  CircRNA_0043691 sponges miR-873-3p to promote metastasis of gastric cancer.

Authors:  Yu Zhang; Gengyuan Hu; Zhenxing Zhang; Yuanming Jing; Feng Tao; Minfeng Ye
Journal:  Mamm Genome       Date:  2021-08-09       Impact factor: 2.957

5.  LCN2 Mediated by IL-17 Affects the Proliferation, Migration, Invasion and Cell Cycle of Gastric Cancer Cells by Targeting SLPI.

Authors:  Jing Xu; ShengXiang Lv; Wei Meng; Fang Zuo
Journal:  Cancer Manag Res       Date:  2020-12-14       Impact factor: 3.989

Review 6.  LINC00261: a burgeoning long noncoding RNA related to cancer.

Authors:  Menggang Zhang; Fang Gao; Xiao Yu; Qiyao Zhang; Zongzong Sun; Yuting He; Wenzhi Guo
Journal:  Cancer Cell Int       Date:  2021-05-22       Impact factor: 5.722

7.  Revealing the transcriptional heterogeneity of organ-specific metastasis in human gastric cancer using single-cell RNA Sequencing.

Authors:  Haiping Jiang; Dingyi Yu; Penghui Yang; Rongfang Guo; Mei Kong; Yuan Gao; Xiongfei Yu; Xiaoyan Lu; Xiaohui Fan
Journal:  Clin Transl Med       Date:  2022-02

Review 8.  Interaction of ncRNA and Epigenetic Modifications in Gastric Cancer: Focus on Histone Modification.

Authors:  Qingfan Yang; Yu Chen; Rui Guo; Yalan Dai; Liyao Tang; Yueshui Zhao; Xu Wu; Mingxing Li; Fukuan Du; Jing Shen; Tao Yi; Zhangang Xiao; Qinglian Wen
Journal:  Front Oncol       Date:  2022-01-26       Impact factor: 6.244

Review 9.  Recent Advances in Anti-Metastatic Approaches of Herbal Medicines in 5 Major Cancers: From Traditional Medicine to Modern Drug Discovery.

Authors:  Jinkyung Park; Dahee Jeong; Meeryoung Song; Bonglee Kim
Journal:  Antioxidants (Basel)       Date:  2021-03-27

10.  PADI4 promotes epithelial-mesenchymal transition(EMT) in gastric cancer via the upregulation of interleukin 8.

Authors:  Xiao-Tian Chang; Hui Wu; Hui-Lin Li; Hong-Lei Li; Ya-Bing Zheng
Journal:  BMC Gastroenterol       Date:  2022-01-19       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.